Fieldpoint Private Securities, LLC Neurocrine Biosciences Inc Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 1,046 shares of NBIX stock, worth $120,917. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,046
Previous 1,088
3.86%
Holding current value
$120,917
Previous $102,000
-0.0%
% of portfolio
0.03%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
95.2MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.64 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$565 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$349 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$293 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...